yeka adoke - Infectious Diseases

Author Information

Yeka Adoke is a researcher affiliated with the Infectious Diseases Research Collaboration (IDRC) located on Nakasero Hill Road in Kampala, Uganda. His work primarily focuses on malaria research, exploring various aspects such as treatment efficacy, drug resistance, and public health strategies to combat malaria transmission and improve patient outcomes.

Research Contributions

Yeka Adoke has made significant contributions to the field of infectious diseases, with a particular emphasis on malaria. His research encompasses clinical trials investigating the efficacy and safety of antimalarial drugs, studies on molecular markers of drug resistance, and public health interventions like insecticide-treated nets and indoor residual spraying. He has also explored issues related to neonatal health and anaemia in Ugandan children, contributing valuable insights into both malaria-specific and broader public health challenges.

Aliases

There are no aliases listed for Yeka Adoke in the provided data.

Publication and Citation Metrics

Metric	Count
Citation Count	226
H-index	9
Paper Count	15

Publications:

A randomized, double-blind, phase 2b study to investigate the efficacy, safety, tolerability and pharmacokinetics of a single-dose regimen of ferroquine with artefenomel in adults and children with uncomplicated Plasmodium falciparum malaria

DOI: 10.1186/s12936-021-03749-4

Year: 2021

Efficacy and Safety of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for The Treatment of Uncomplicated Plasmodium Falciparum Malaria and Prevalence of Molecular Markers Associated With Artemisinin and Partner Drug Resistance in Uganda

DOI: 10.21203/RS.3.RS-738188/V1

Year: 2021

Survival time and its predictors in preterm infants in the post-discharge neonatal period: a prospective cohort study in Busoga Region, Uganda

DOI: 10.1016/s2214-109x(20)30147-9

Year: 2020

African isolates show a high proportion of multiple copies of the Plasmodium falciparum plasmepsin-2 gene, a piperaquine resistance marker

DOI: 10.1186/s12936-019-2756-4

Year: 2019

Long lasting insecticidal bed nets ownership, access and use in a high malaria transmission setting before and after a mass distribution campaign in Uganda

DOI: 10.1371/journal.pone.0191191

Year: 2018

Survival time and its predictors among preterms in the neonatal period post-discharge in Busoga region-Uganda June – July 2017

DOI: 10.37432/jieph.2019.2.2.19

Year: 2018

Factors associated with willingness to take up indoor residual spraying to prevent malaria in Tororo district, Uganda: a cross-sectional study

DOI: 10.1186/s12936-017-2163-7

Year: 2017

Prevalence and factors associated with anaemia among children aged 6 to 59 months in Namutumba district, Uganda: a cross- sectional study

DOI: 10.1186/s12887-017-0782-3

Year: 2017

A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria

DOI: 10.1186/s12916-017-0940-3

Year: 2017

Cost Effectiveness of Giemsa versus Field’s Staining Technique: Implications for Malaria Diagnosis among Children in a Busy Hospital Setting in Uganda

DOI: 10.33805/2573-3877.106

Year: 2016

What Role Do Phagocytes Play?

What Are Some Key Infectious Diseases Monitored by WHO?

What are Sporozoites?

How Does RT-PCR Work?

Can Climate Change Influence Antibiotic Resistance?

How are Resources Prioritized?

Why is a Malaria Vaccine Important?

What is a Rash?

How Do B Cells Interact with T Cells?

What Are the General Principles of Treatment?

Partnered Content Networks

Relevant Topics